2006 - Institut für Klinische Chemie - UniversitätsSpital Zürich

Nitsch D, Dietrich DF, von Eckardstein A, Gaspoz JM, Downs SH, Leuenberger P, Tschopp JM, Brandli
O, Keller R, Gerbase MW, Probst-Hensch NM, Stutz EZ, Ackermann-Liebrich U; SAPALDIA team
(2006): Prevalence of renal impairment and its association with cardiovascular risk factors in a general
population: results of the Swiss SAPALDIA study. In: Nephrology, dialysis, transplantation 21(4), 935-44
Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G. (2006):
Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. In: Journal of lipid research
47(4), 794-803
Reitz C, Kretzschmar K, Roesler A, von Eckardstein A, Berger K (2006): Relation of plasma thyroidstimulating
hormone levels to vascular lesions and atrophy of the brain in the elderly. In: Neuroepidemiology
27(2), 89-95
Rohrer L, Cavelier C, Fuchs S, Schluter MA, Volker W, von Eckardstein A. (2006): Binding, internalization
and transport of apolipoprotein A-I by vascular endothelial cells. In: Biochimica et biophysica acta
1761(2), 186-94
Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M (2006): Comparable
increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients
with severe sepsis, septic shock, and acute heart failure. In: Critical care medicine 34(8), 2140-4
Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM.
(2006): Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal
cerebral ischemia. In: Nature neuroscience 9(4), 487-8
Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Bjorkhem I,
Lutjohann D. (2006): Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not
of pravastatin. In: The Journal of pharmacology and experimental therapeutics 316(3), 1146-52
Ulrich S, Debrunner J, Stoll S, Rentsch K, Bachli EB. (2006): A single dose of oral vitamin K effectively
reverses oral anticoagulation with phenprocoumon during heart catheterisation. In: Swiss medical
weekly 136(43-44), 691-5
Wittwer J, Marti-Jaun J, Hersberger M. (2006): Functional polymorphism in ALOX15 results in increased
allele-specific transcription in macrophages through binding of the transcription factor SPI1. In: Human
mutation 27(1), 78-87
Wollmer MA, Kapaki E, Hersberger M, Muntwyler J, Brunner F, Tsolaki M, Akatsu H, Kosaka K, Michikawa
M, Molyva D, Paraskevas GP, Lutjohann D, von Eckardstein A, Hock C, Nitsch RM, Papassotiropoulos
A. (2006): Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer’s disease. In:
American journal of medical genetics. Part B, Neuropsychiatric genetics 141(5), 534-6
Übersichtsartikel/Reviews mit Peer Review
Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A (2006): Lipid Efflux by the ATP Binding Cassette
Transporters ABCA1 and ABCG1 In: Biochimica et biophysica acta 1761(7), 655-66
Jaquenoud Sirot E, van der Velden JW, Rentsch K, Eap CB, Baumann P (2006): Therapeutic drug
monitoring and pharmacogenetic tests as tools in pharmacovigilance In: Pharmacoepidemiology and
drug safety 29(9), 735-68
von Eckardstein A (2006): Differential Diagnosis of Familial High Density Lipoprotein Deficiency Syndromes
In: Atherosclerosis 186, 231-239
Übersichtsartikel/Reviews ohne Peer Review
Rentsch K, Baumann P, Fathi M, Grignaschi N, Magnin JL, Thormann W, Todesco L, Wenk M, Werner
D (2006): Monographs on drugs, which are frequently analysed in the course of Therapeutic Drug
Monitoring In: Laboratoriums-Medizin. Journal of laboratory medicine 30, 443-452
Institut für Klinische Chemie
Akademischer Bericht 2006
18